Research Topics
Genomes and GenesSpecies | Bianca Weinstock-GuttmanSummaryAffiliation: State University of New York Country: USA Publications
| Collaborators
|
Detail Information
Publications
Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosisBianca Weinstock-Guttman
Department of Neurology, State University of New York, Buffalo, NY 14203, USA
J Neurol Sci 311:86-91. 2011....
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MSBianca Weinstock-Guttman
Jacobs Neurological Institute, Buffalo, NY 14203 1126, USA
J Neurol 259:898-905. 2012..001). These analyses underline beneficial effects of natalizumab therapy in relapsing MS patients...
Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease)Bianca Weinstock-Guttman
The William C Baird Multiple Sclerosis Center, Jacobs Neurological Institute, State University of New York, Buffalo, NY 14203, USA
Arch Neurol 63:957-63. 2006..Mitoxantrone hydrochloride, a synthetic anthracenedione approved for worsening relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis, has been shown to primarily suppress the humoral response...
Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis opticaB Weinstock-Guttman
Baird Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, NY Department of Neurology, State University of New York at Buffalo, Buffalo, NY 14203, USA
Mult Scler 14:1061-7. 2008..To determine whether neuromyelitis optica (NMO) immunoglobulin (IgG) antibody status in NMO/Devic's disease patients followed prospectively is persistent or can change relative to the clinical status and/or response to therapy...
Interferon-beta treatment for relapsing multiple sclerosisBianca Weinstock-Guttman
The Jacobs Neurological Institute, Department of Neurology, University at Buffalo, State University of New York, Buffalo, NY 14203, USA
Expert Opin Biol Ther 8:1435-47. 2008..Recombinant forms of IFN-beta were the first therapeutic intervention found to be effective at interfering with the course of multiple sclerosis (MS), a chronic and debilitating disease affecting the CNS in young adults...
Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosisBianca Weinstock-Guttman
Department of Neurology, State University of New York, Buffalo, NY, USA
J Neuroinflammation 8:127. 2011..Vascular co-morbidities are associated with increased risk of progression. Dyslipidemia, elevated LDL and reduced HDL may increase progression by activating inflammatory processes at the vascular endothelium...
Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosisZohara Sternberg
Department of Neurology, Baird MS Center, Jacobs Neurological Institute, 100 High St, Buffalo, NY 14203, USA
J Neuroinflammation 7:72. 2010....
Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosisRalph H B Benedict
Department of Neurology, School of Medicine, State University of New York at Buffalo, 100 High Street, Buffalo, NY 14203, USA
Arch Neurol 63:1301-6. 2006..Cognitive dysfunction is common in multiple sclerosis (MS). Correlations are reported between atrophy and neuropsychological test results...
Cortical atrophy and personality in multiple sclerosisRalph H B Benedict
Department of Neurology, State University of New York at Buffalo, School of Medicine, New York, USA
Neuropsychology 22:432-41. 2008..These findings suggest that cortical atrophy in MS is associated with adverse impact on personality, although longitudinal research is needed to test this hypothesis...
Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiencyRobert Zivadinov
Buffalo Neuroimaging Analysis Center, University at Buffalo, Buffalo, NY, USA
BMC Neurol 11:128. 2011....
Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burdenRalph H B Benedict
Department of Neurology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo General Hospital, NY 14203, USA
Arch Neurol 61:226-30. 2004..Furthermore, few studies accounted for the influence of age, premorbid intelligence, or depression...
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal studyRobert Zivadinov
Department of Neurology, School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, 100 High St, Buffalo, NY 14203, USA
Neurol Res 34:761-9. 2012..To prospectively investigate the associations of baseline serum anti-phospholipid antibody (APLA) status on evolution of clinical and MRI measures in a multiple sclerosis (MS) patient cohort treated with interferon-beta (IFN-beta)...
Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patientsBianca Weinstock-Guttman
Jacobs Neurological Institute, Buffalo General Hospital, Buffalo, NY 14203, United States
J Neuroimmunol 182:236-9. 2007..No significant association was found between the MXA genotype at these two SNPs and clinical, MRI and MXA gene expression in MS patients treated with IFN-beta therapy...
Interferon inhibitory activity in patients with multiple sclerosisKailash Chadha
Department of Cell and Molecular Biology, Roswell Park Cancer Institute, Jacobs Neurological Institute, Buffalo, New York 14263, USA
Arch Neurol 63:1579-84. 2006..Interferon inhibitory activity (IIA) is a logical candidate for explaining neutralizing antibody-negative partial responsiveness to interferon beta in multiple sclerosis (MS), but its role has not been evaluated...
Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patientsBianca Weinstock-Guttman
Jacobs Neurological Institute, Buffalo General Hospital, Buffalo, NY 14203, United States
J Neuroimmunol 205:113-25. 2008....
Heart disease, overweight, and cigarette smoking are associated with increased prevalence of extra-cranial venous abnormalitiesKresimir Dolic
Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, NY 14203, USA
Neurol Res 34:819-27. 2012....
Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-betaZohara Sternberg
Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY, USA
J Neuroinflammation 6:28. 2009..Luteolin reduced the MMP-9/TIMP-1 ratio via lowering MMP-9 production. In the majority of cases, luteolin, when combined with IFN-beta, had additive effects in modulating cell proliferation, IL-1beta, TNF-alpha, MMP-9 and TIMP-1...
Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive declineSarah A Morrow
The Jacobs Neurological Institute, State University of New York at Buffalo, NY 14203, USA
Clin Neuropsychol 24:1131-45. 2010..8), accounting for 86.7% of the area under the ROC curve. We conclude that decline on NP testing over time is predictive of deterioration in vocational status, establishing a magnitude of decline on NP tests that is clinically meaningful...
Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patientsBianca Weinstock-Guttman
Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY 14260, USA
J Neurol Neurosurg Psychiatry 82:189-95. 2011..This research evaluates the significance of vitamin D and its active metabolites in brain tissue injury and clinical disability in MS patients...
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)Ralph H B Benedict
State University of New York at Buffalo School of Medicine, Department of Neurology, Division of Departmental and Behavioral Neurosciences, Buffalo, New York, USA
J Int Neuropsychol Soc 12:549-58. 2006..We conclude that the MACFIMS is a valid approach to routine NP assessment of MS patients. Future work is planned to determine its psychometric properties in a longitudinal study...
Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior changeRalph H B Benedict
Department of Neurology, School of Medicine, State University of New York at Buffalo, Buffalo General Hospital, Neurology, Suite D 6, 100 High Street, Buffalo, NY 14203, USA
J Neurol Sci 231:29-34. 2005..The findings highlight core clinical problems that merit early identification and further research regarding the development of effective treatment...
Plasma pentosidine: a potential biomarker in the management of multiple sclerosisZohara Sternberg
Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY, USA
Mult Scler 17:157-63. 2011..The chronic inflammation associated with multiple sclerosis (MS) may lead to the upregulation of pentosidine...
Arterial, venous and other vascular risk factors in multiple sclerosisYuval Karmon
The Jacobs Neurological Institute, Department of Neurology, University at Buffalo, State University of New York, Buffalo, NY, USA
Neurol Res 34:754-60. 2012..Future work in this direction is required in order to better elucidate the role of lipid metabolism and vascular pathology in pathogenesis of MS...
Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteersKresimir Dolic
Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, New York, United States of America
PLoS ONE 6:e28062. 2011....
Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosisDeborah M Miller
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Mult Scler 9:1-5. 2003....
Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factorRobert Zivadinov
Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY 14260, USA
Hum Mol Genet 16:2659-68. 2007..There were no significant associations between Met66 allele status and other neurocognitive measures. The BDNF Met66 allele is associated with lower damage as evidenced by measurement of NGMV and T2-LV in MS patients...
Genomic effects of IFN-beta in multiple sclerosis patientsBianca Weinstock-Guttman
Jacobs Neurological Institute, Buffalo General Hospital, Buffalo, NY 14203, USA
J Immunol 171:2694-702. 2003..The findings demonstrate that IFN-beta treatment induces specific and time-dependent changes in multiple mRNAs in lymphocytes of multiple sclerosis patients that could provide a framework for rapid monitoring of the response to therapy...
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosisBianca Weinstock-Guttman
Department of Neurology, State University of New York, Buffalo, NY, USA
BMC Neurol 12:26. 2012..healthy controls (HC) (56.1% vs. 22.7%, p < 0.001).The objective was to evaluate the clinical correlates of venous anomalies indicative of CCSVI in patients with MS...
Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control studyJesper Hagemeier
Buffalo Neuroimaging Analysis Center, University at Buffalo, Buffalo, New York, USA
J Magn Reson Imaging 36:73-83. 2012..To relate phase lesion characteristics to other clinical and MRI outcomes...
Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosisMathew Foster
Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, USA
J Neuroimmunol 243:61-8. 2012..To examine the associations of alcohol consumption patterns with disability and brain injury in multiple sclerosis (MS) patients...
Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosisAyda Tekok Kilic
Department of Neurology, University at Buffalo, State University of New York, USA
Neuroimage 36:1294-300. 2007..For the first time, we show an independent relationship between cortical atrophy and cognitive impairment after accounting for the effects of central atrophy...
Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patientsBianca Weinstock-Guttman
Jacobs Neurological Institute, Buffalo General Hospital, Buffalo, NY 14203, USA
Mult Scler 12:541-50. 2006..CONCLUSIONS: IFN-beta treatment induces complex, specific and time-dependent changes in multiple proteins and mRNAs related to bone homeostasis in MS patients...
Upper and lower extremity motor function and cognitive impairment in multiple sclerosisRalph H B Benedict
Department of Neurology, SUNY Buffalo School of Medicine, Buffalo, NY, USA
J Int Neuropsychol Soc 17:643-53. 2011..The findings may have implications for risk assessment and treatment of mobility dysfunction in MS...
Gray matter SWI-filtered phase and atrophy are linked to disability in MSJesper Hagemeier
Department of Neurology, School of Medicine and Biomedical Sciences, Buffalo Neuroimaging Analysis Center, 100 High Street, Buffalo, NY 14203, USA
Front Biosci (Elite Ed) 5:525-32. 2013..Our findings suggest that disability in MS patients is associated better with SDGM pathology, as indicated by increased iron content and atrophy, than with lesion burden or white matter and cortical volumes...
Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patientsBianca Weinstock-Guttman
Department of Neurology, State University of New York, Buffalo, New York, United States of America
PLoS ONE 6:e16802. 2011..The objective was to assess the associations between HLA DRB1*1501 status and the occurrence of CCSVI in MS patients...
Validity of the California Verbal Learning Test-II in multiple sclerosisShane Stegen
Department of Neurology, State University of New York SUNY at Buffalo, Buffalo, NY, USA
Clin Neuropsychol 24:189-202. 2010..We conclude that the CVLT-II is a valid test in MS and provides a rich constellation of verbal memory measures...
MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosisMilena Stosic
Department of Neurology, School of Medicine and Biomedical Sciences, State University of New York, Buffalo, NY 14203, USA
J Neurol 257:63-71. 2010..MRI reveals more profound injury in patients with MS versus PAPLS. APLA mediates heterogeneous cerebral pathology that remains to be further investigated...
Quantitative diffusion weighted imaging measures in patients with multiple sclerosisEleonora Tavazzi
Buffalo Neuroimaging Analysis Center, Department of Neurology, University at Buffalo, State University of New York, Buffalo, NY, USA
Neuroimage 36:746-54. 2007..ENT is a sensitive marker of overall brain damage that is strongly related to clinical impairment in patients with SP MS...
Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensityRobert A Bermel
Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, USA
Arch Neurol 62:1371-6. 2005..We hypothesize that interferon beta may exert its effect on brain atrophy in part by reducing a cascade of events that involve iron deposition as a mediator of neurotoxicity or as a disease epiphenomenon...
Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosisErica Grazioli
Jacobs Neurological Institute, Buffalo General Hospital, Buffalo, NY 14203, USA
J Neurol Sci 268:12-7. 2008..067). There was negative correlation between average RNFL thickness (average of both eyes) and disability as assessed by EDSS (p=0.02). The results support potential usefulness of OCT for MS patient monitoring and research applications...
Regional lobar atrophy predicts memory impairment in multiple sclerosisRalph H B Benedict
Department of Neurology, SUNY Buffalo School of Medicine, Buffalo, NY 14203, USA
AJNR Am J Neuroradiol 26:1824-31. 2005..42-0.64). CONCLUSION: Regional atrophy accounts for more variance than lesion burden, whole brain atrophy, or lateral ventricle volume in predicting multiple sclerosis-associated memory dysfunction...
Immune cell BDNF secretion is associated with white matter volume in multiple sclerosisBianca Weinstock Guttman
Jacobs Neurological Institute, Buffalo General Hospital, Buffalo, NY 14203, United States
J Neuroimmunol 188:167-74. 2007..To investigate the relationship between immune cell secretion of brain-derived neurotrophic factor (BDNF) with clinical and MRI variables in multiple sclerosis (MS) patients...
Risk of bone loss in men with multiple sclerosisBianca Weinstock-Guttman
Baird MS Center, The Jacobs Neurological Institute, 100 High Street, Buffalo, NY 14203, USA
Mult Scler 10:170-5. 2004..Emerging data suggest a significantly increased prevalence of osteoporosis in men and women with multiple sclerosis (MS) compared to age-matched controls, but no specific clinical testing recommendations are available for men...
Health-related quality of life in multiple sclerosis: effects of natalizumabRichard A Rudick
Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Ann Neurol 62:335-46. 2007..To report the relationship between disease activity and health-related quality of life (HRQoL) in relapsing multiple sclerosis, and the impact of natalizumab...
Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot StudyRobert Zivadinov
Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, NY 14203, USA E Mails S H N B E C J D M G D C K
Int J Mol Sci 13:5659-73. 2012..the 1.5 T protocol (p = NS for both time points). This MRI mechanistic study suggests that GA may exert a greater effect on decreasing lesion activity as measured on 3 T optimized compared to 1.5 T standard protocol...
The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correctionMichael P Sanfilipo
Department of Neurology, SUNY-University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY 14203, USA
Neuroimage 26:1068-77. 2005..These findings suggest that gray matter loss is related to other aspects of brain pathology and has more clinical relevance than white matter atrophy in MS...
Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosisRalph H B Benedict
Department of Neurology, State University of New York SUNY at Buffalo, School of Medicine, Buffalo, NY 14203, USA
Mult Scler 13:722-30. 2007..Given its overall simplicity and moderate correlation with cognition, DWI may offer several logistic advantages over more traditional MRI measures when predicting the presence of NP impairment...
Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosisBrett A Parmenter
Department of Neurology, State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY 14203, USA
J Clin Exp Neuropsychol 29:215-23. 2007..While both tests appear to have good validity in the MS population, the availability of alternative forms makes the DKEFS an attractive alternative to the WCST, as was suggested by a consensus panel...
Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patientsZohara Sternberg
Department of Neurology, Baird MS Center, Jacobs Neurological Institute, Buffalo, NY 14223, United States
J Neuroimmunol 205:142-7. 2008..Quercetin, when combined with IFN-beta, had additive effects in modulating TNF-alpha and MMP-9. These immunomodulatory responses to quercetin were similar between MS patients and healthy control (HC) subjects...
Clinical efficacy, effects on MRI and tolerability of weekly intramuscular interferon-beta-1a in patients with MS and CISRobert Zivadinov
Buffalo Neuroimaging Analysis Center, Department of Neurology, University at Buffalo, State University of New York, Buffalo, New York 14203, USA
Drugs Today (Barc) 44:601-13. 2008..Early initiation of disease-modifying therapy after the diagnosis of relapsing-remitting MS or after a single demyelinating event (and evidence of lesions on MRI) allows patients the opportunity to obtain maximal long-term benefits...
Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectivesRobert Zivadinov
Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, NY, USA
Expert Rev Neurother 11:1277-94. 2011..The potential usefulness of endovascular treatment for CCSVI in multiple sclerosis patients is still unknown...
Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control studyRobert Zivadinov
Buffalo Neuroimaging Analysis Center, University at Buffalo, Buffalo, NY 14203, USA
Neuroimage 59:331-9. 2012....
Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosisMichael P Sanfilipo
Department of Neurology, SUNY-University, School of Medicine and Biomedical Sciences, Buffalo, NY, USA
Neurology 66:685-92. 2006..CONCLUSION: Both gray and white brain matter atrophy contribute to neuropsychological deficits in multiple sclerosis...
Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitisMichael Valerio
SUNY at Buffalo, 2 Sherman Hall, Buffalo, NY 14214, USA
Inflamm Res 60:457-65. 2011..Using experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS), the objective of this study was to examine the effect of phytosterol (PS) administration on inflammation-based EAE development...
Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry studyDeepa P Ramasamy
Buffalo Neuroimaging Analysis Center, Department of Neurology, State University of New York, Buffalo, NY, USA
Pathophysiology 18:53-60. 2011..Future studies are warranted to investigate longitudinally possible protective role of the Met66 allele of the BDNF rs6265 SNP in relation to specific GM regions...
Combination therapy for multiple sclerosis: the treatment strategy of the future?Bianca Weinstock-Guttman
Baird MS Research Center of The Jacobs Neurological Institute, Buffalo, New York 14203, USA
CNS Drugs 18:777-92. 2004..Ultimately, the optimal therapies will likely include strategies that promote repair and limit tissue destruction in combination with anti-inflammatory interventions...
The nervous system's potential role in multiple sclerosis associated bone lossSowmya Josyula
Dept of Neurology, SUNY Buffalo, 100 High Street, Buffalo, NY 14203, USA
J Neurol Sci 319:8-14. 2012....
Cine cerebrospinal fluid imaging in multiple sclerosisChristopher Magnano
Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, New York, USA
J Magn Reson Imaging 36:825-34. 2012..To investigate cerebrospinal fluid (CSF) dynamics in the aqueduct of Sylvius in multiple sclerosis (MS) patients and healthy controls (HC) using cine phase contrast imaging...
Vitamin D and multiple sclerosisBianca Weinstock-Guttman
Jacobs Neurological Institute, Buffalo, NY 14203, USA
Neurologist 18:179-83. 2012..In vitro studies have expanded the potential role of vitamin D and its receptor beyond calcium modulation, regulation, and maintenance of bone mineralization, to include immune modulation...
Patterns of dietary and herbal supplement use by multiple sclerosis patientsKerri O'Connor
Department of Pharmaceutical Sciences, State University of New York, 427 Cooke Hall, Buffalo, NY 14260, USA
J Neurol 259:637-44. 2012..Dietary supplements are used more frequently by MS patients than controls. Use tends to increase after MS onset compared to before, especially for DS. The use of HS by MS patients is only modestly greater than by controls...
Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patientsLaura Hartrich
Department of Pathology, State University of New York at Buffalo, Buffalo, NY 14260-1200, USA
J Neuroimmunol 139:84-92. 2003..The activated NK cell levels after prolonged therapy may potentially provide a surrogate marker for IFN-beta exposure...
Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosisRobert Zivadinov
Buffalo Neuroimaging Analysis Center, Department of Neurology, University at Buffalo, State University of New York, Buffalo, NY, USA
J Neuroimmunol 209:123-30. 2009....
Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patientsBianca Weinstock-Guttman
Baird Multiple Sclerosis Center for MS Treatment and Research, Jacobs Neurological Institute, State University of New York, Buffalo General Hospital E2, 14203, USA
Prostaglandins Leukot Essent Fatty Acids 73:397-404. 2005..12 relapses/year (P = 0.021) vs. -0.69 +/- SD 1.11 (P = 0.044) in the OO group. This study suggests that a low fat diet supplemented with omega-3 PUFA can have moderate benefits in RRMS patients on concurrent disease modifying therapies...
Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patientsForum Desai
Department of Exercise and Nutrition Sciences, State University of New York, Buffalo, NY 14214, USA
Int Immunopharmacol 9:153-7. 2009..The results show that SIT is effective in modulating the secretion of pro/anti-inflammatory cytokines and suggest a potential beneficial effect of SIT in MS management without the side effects associated with statin therapy...
The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosisBianca Weinstock-Guttman
Jacobs Neurological Institute, Department of Neurology, Buffalo General Hospital, Buffalo, NY 14203, United States
Pathophysiology 18:43-52. 2011..Conclusions: The C allele of BDNF rs2030324 is associated with protection against visual cognitive processing deficits via mechanisms that appear associated with the volume of the thalamus...
Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomesEluen Ann Yeh
Pediatric MS and Demyelinating Disorders Center of the Jacobs Neurological Institute, Women and Children s Hospital of Buffalo, Buffalo, NY 14222, USA
Expert Rev Neurother 11:433-40. 2011..This article will explore this paradox, taking into account studies that have focused on neuroimaging, cognition and outcomes in pediatric MS...
Reliable screening for neuropsychological impairment in multiple sclerosisRalph H B Benedict
Department of Neurology, State University of New York at Buffalo, School of Medicine, Buffalo, New York, NY, USA
Mult Scler 10:675-8. 2004..It is concluded that the MSNQ is useful, although patient self-reports may be exaggerated in depressed patients or reduced in patients with severe cognitive impairment...
Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging studyAndrew J Fabiano
Buffalo Neuroimaging Analysis Center, Jacobs Neurological Institute, 100 High Street, Buffalo, NY 14203, USA
J Neuroimaging 13:307-14. 2003..Both indirect and direct mechanisms of gray matter injury may play a role in the pathophysiology of MS...
Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentationJitendra Sharma
Buffalo Neuroimaging Analysis Center, University at Buffalo, State University of New York, Buffalo, NY, USA
AJNR Am J Neuroradiol 25:985-96. 2004..They discriminated MS from healthy individuals and showed similar relationships to established disease variables...
Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis ConsortiumIlya Kister
Multiple Sclerosis Care Center, Department of Neurology, New York University School of Medicine, NYU Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003 3804, USA
Mult Scler 17:725-33. 2011..Although the natural history of multiple sclerosis has been charted extensively, it is still not known whether the trajectory of disability accumulation has changed in the era of disease-modifying therapies (DMTs)...
Iron deposition and inflammation in multiple sclerosis. Which one comes first?Robert Zivadinov
Buffalo Neuroimaging Analysis Center, University at Buffalo, Buffalo, NY, USA
BMC Neurosci 12:60. 2011..Creating a representative animal model that can study independently such relationship will be the key factor in this endeavor...
Personality traits in women with multiple sclerosis: discrepancy in patient/partner report and disease courseRalph H B Benedict
State University of New York at Buffalo School of Medicine, Departments of Neurology and Psychiatry, Buffalo, NY, USA
J Psychosom Res 66:147-54. 2009..We endeavored to examine the extent to which patients' self-perceptions are congruent with how they are perceived by significant others across five trait domains as demarcated by the well known Five-Factor Model (FFM)...
Construct validity and frequency of euphoria sclerotica in multiple sclerosisInna Fishman
State University of New York (SUNY) Buffalo School of Medicine and Biomedical Sciences, Buffalo General Hospital, Buffalo, New York, USA
J Neuropsychiatry Clin Neurosci 16:350-6. 2004..Thus, we used the NPI to validate the euphoria syndrome in multiple sclerosis (MS) and determined its frequency, and its neurological and psychological correlates...
A phase 3 trial of extended release oral dalfampridine in multiple sclerosisAndrew D Goodman
Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA
Ann Neurol 68:494-502. 2010..The current study was designed to confirm efficacy and further define safety and pharmacodynamics...
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinicianAaron Boster
The Multiple Sclerosis Clinical Research Center, Department of Neurology, Wayne State University School of Medicine, and The Detroit Medical Center, Detroit, MI 48201, USA
Lancet Neurol 7:173-83. 2008..This Review describes the use of intense immunosuppressant drugs and natalizumab in patients with rapidly worsening MS and provides clinicians with guidelines for the use of these drugs in this patient group...
Functional imaging during covert auditory attention in multiple sclerosisMichael P Santa Maria
Department of Neurology, School of Medicine, State University of New York at Buffalo, Buffalo General Hospital, Neurology, Suite D-6 Buffalo, 100 High Street, 14203, USA
J Neurol Sci 218:9-15. 2004..This study demonstrates cingulate hypoactivity and cerebral reorganization during auditory attention in MS...
Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patientsLinh T Nguyen
Department of Pharmaceutical Sciences, State University of New York at Buffalo, 543 Cooke Hall, Buffalo, NY 14260-1200, USA
J Neurol Sci 209:93-9. 2003..49, P=0.018). The secretion of the pro-inflammatory cytokines, IFN-gamma and TNF-alpha, is influenced by gender in MS patients and may contribute to the sexual dimorphism of MS...
